|1|Predicting 10-year quality-of-life outcomes of patients with schizophrenia and schizoaffective disorders. (24405469)
Ritsner M.S.... Grinshpoon A.
|2|Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression. (23517884)
Turkoz I.... Alphs L.
|3|Regarding "A Risperidone-induced Prolactinoma Resolved When A Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report". (23556137)
Coppola D.... Hough D.
|4|Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family. (23341099)
Myles-Worsley M.... Middleton F.A.
|5|Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). (24167692)
Smeraldi E.... Schreiner A.
|6|Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder. (23276482)
Pandina G.... Alphs L.
|7|Cognitive impairments in schizophrenia and schizoaffective disorder: relationship with clinical characteristics. (22456585)
Torniainen M.... Tuulio-Henriksson A.
|8|Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study. (22454251)
Schoemaker J.... Emsley R.
|9|The use of electroconvulsive therapy to treat schizoaffective disorder in a patient with pacemaker: a case report. (22706421)
Kuzman M.R.... Bradas Z.
|10|Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls. (22357405)
Amann B.... Pomarol-Clotet E.
|11|A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. (22697191)
Williams J.M.... George T.P.
|12|Oral paliperidone: a review of its use in the management of schizoaffective disorder. (21649452)
|13|Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls. (21106252)
Nolan K.A.... Hoptman M.J.
|14|White matter integrity and lack of insight in schizophrenia and schizoaffective disorder. (21429714)
Antonius D.... Hoptman M.J.
|15|Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment. (20452677)
Kaneda Y.... Meltzer H.
|16|Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report. (21240152)
Saatcioglu O.... Yanik M.
|17|Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers. (20814330)
Canuso C.M.... Lindenmayer J.P.
|18|Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. (19164494)
Elie D.... Grignon S.
|19|Aripiprazole in schizophrenia and schizoaffective disorder: A review. (20152550)
Stip E.... Tourjman V.
|20|Association of Per3 gene with bipolar disorder: comment on "Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia". (21176035)
Rocha P.M.... CorrA-a H.
|21|Valproic acid-induced myopathy in a patient with schizoaffective disorder. (19593189)
Reiche I.... Bode-BAPger S.M.
|22|Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study. (19358789)
DA-az-MarsA! M.... Rico-Villademoros F.
|23|Clinical and pharmacoeconomic evaluation of switch to olanzapine in veterans with schizophrenia or schizoaffective disorder. (18362873)
Davis L.L.... Kashner T.M.
|24|Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability. (17472821)
Thyssen A.... Mannaert E.
|25|Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. (17878500)
Kilbourne A.M.... Post E.P.
|26|Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder. (17049818)
Lindenmayer J.P.... Kushner S.
|27|A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use. (17145274)
Shoval G.... Weizman A.
|28|Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy. (17010994)
Lipkovich I.... Houston J.P.
|29|Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. (16687995)
Gharabawi G.M.... Amador X.
|30|Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. (16953381)
Andrezina R.... Iwamoto T.
|31|Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics. (16376522)
Nakonezny P.A.... Byerly M.J.
|32|Bipolar and depressive types of schizoaffective disorder in old age. (16582048)
Baran X.Y.... Young R.C.
|33|White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. (15741480)
Szeszko P.R.... Lim K.O.
|34|Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. (15705006)
Brar J.S.... Mahmoud R.
|35|Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study. (16507379)
Meyer J.M.... Greenspan A.
|36|Long-acting risperidone in stable patients with schizoaffective disorder. (16144783)
Mohl A.... Medori R.
|37|Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population. (16043131)
Clark D.A.... Kerwin R.W.
|38|Treatment of hepatitis B and C co-infection in schizoaffective disorder. (16170206)
Balasubramanian S.... Bourgeois J.A.
|39|Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. (15889952)
Glick I.D.... Marder S.R.
|40|Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. (14744169)
Volavka J.... Lieberman J.A.
|41|Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. (12614996)
Hibbeln J.R.... Fenton W.S.
|42|Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. (12860772)
Potkin S.G.... Marder S.R.
|43|Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. (12202271)
van Erp T.G.... Cannon T.D.
|44|Maintenance electroconvulsive therapy in affective and schizoaffective disorder. (11150895)
Swoboda E.... Hansen M.
|45|Treatment of schizoaffective disorder with divalproex sodium. (11099889)
DelBello M.P.... Strakowski S.M.
|46|Use of the CAGE questionnaire in older adults with schizophrenia or schizoaffective disorder. (10438700)
Lehman M.S.... Kettl P.
|47|Treatment of schizoaffective disorder and schizophrenia with mood symptoms. (10450252)
Levinson D.F.... Musthaq M.
|48|Wernicke-Korsakoff amnestic syndrome secondary to malnutrition in a patient with schizoaffective disorder. (9845417)
Newman M.E.... Jampala V.C.
|49|Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. (9712207)
Reid W.H.... Hogan T.
|50|Lamotrigine in the treatment of schizoaffective disorder. (9778612)
Erfurth A.... Grunze H.